XML 37 R27.htm IDEA: XBRL DOCUMENT v3.21.4
SHAREHOLDERS’ EQUITY (Tables)
3 Months Ended
Nov. 30, 2021
Equity [Abstract]  
Schedule of common stock outstanding
          
   November 30, 
   2021   2020 
Common stock outstanding, beginning of quarter   20,141,521    19,923,277 
Common stock issued during the year   27,275    35,483 
Common stock outstanding, end of quarter   20,168,796    19,958,760 
Schedule of dividends declared and paid
                  
(in thousands, except dividend per share)  Fiscal Year 2022         
Record Date  Distribution Date  Number of Shares
Outstanding on
Record Date
   Dividend per
Share
   Total Amount 
10/25/2021  11/01/2021   20,148   $0.06    1,209 
Total               $1,209 

 

(in thousands, except dividend per share)  Fiscal Year 2021         
Record Date  Distribution Date  Number of Shares
Outstanding on
Record Date
   Dividend per
Share
   Total Amount 
10/26/2020  11/02/2020   19,924   $0.06   $1,195 
1/25/2021  2/01/2021   20,010   $0.06    1,201 
4/26/2021  5/03/2021   20,115   $0.06    1,207 
7/26/2021  8/02/2021   20,139   $0.06    1,208 
Total               $4,811 
Schedule of stock option activity
            

(in thousands, except per share and weighted-average amounts)

Transactions during the three months ended November 30, 2021

  Number of
Options
   Weighted-
Average
Exercise
Price
Per Share
   Weighted-
Average
Remaining
Contractual
Life (Years)
 
Outstanding, August 31, 2021   1,184   $25.63    6.47 
Granted   189   $39.19      
Exercised   (28)  $16.88      
Cancelled/Forfeited   (15)  $37.33      
Outstanding, November 30, 2021   1,330   $27.61    6.74 
Exercisable, November 30, 2021   624   $14.47    4.78 
Schedule of fair value of options
        
(in thousands except pricing) 

Three Months Ended

November 30, 2021

   Fiscal Year 2021 
Estimated fair value of awards granted  $3,029   $5,092 
Unvested forfeiture rate   0%    0% 
Weighted average grant price  $39.19   $57.60 
Weighted average market price  $39.19   $57.60 
Weighted average volatility   41.89%    40.49% 
Weighted average risk-free rate   1.44%    0.64% 
Weighted average dividend yield   0.62%    0.42% 
Weighted average expected life   6.60 years    6.63 years 
Schedule of options by exercise price range
                     
(in thousands except prices)                         
Exercise Price   Awards Outstanding   Awards Exercisable 
Low   High   Quantity   Weighted
Average
Remaining
Contractual
Life
   Weighted
Average
Exercise
Price
   Quantity   Weighted
Average
Remaining
Contractual
Life
   Weighted
Average
Exercise
Price
 
$6.85   $9.77    310    3.55 years   $8.39    310    3.55 years   $8.39 
$9.78   $18.76    227    5.09 years   $10.35    169    5.05 years   $10.43 
$18.77   $33.40    280    7.17 years   $25.20    89    6.44 years   $23.64 
$33.41   $49.62    258    9.35 years   $38.27    33    7.76 years   $35.44 
$49.63   $66.14    255    8.97 years   $58.23    23    8.69 years   $60.98 
           1,330    6.74 years   $27.61    624    4.78 years   $14.47